Wistar Scientists Respond

As scientists working at the Wistar Institute of Anatomy and Biology, we were surprised to read in The Scientist (March 2, 1992, page 1) that poor morale, "turmoil," and "bitter divisions" permeate the institute owing to a recent change in leadership. While recognizing the difficulties involved in any transition, we want to stress that this characterization does not reflect the attitudes of scientists who are actively engaged in perpetuating Wistar's success as an independent research institut

Written byScientists Of The
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

While recognizing the difficulties involved in any transition, we want to stress that this characterization does not reflect the attitudes of scientists who are actively engaged in perpetuating Wistar's success as an independent research institution. We want to express our commitment to maintain Wistar's stature as a world-class biomedical research center.

Wistar researchers continue to publish in high-quality, peer-reviewed journals and to compete successfully for federal grants; we play an important role in training basic scientists and young physicians; we maintain strong collaborations with colleagues at other research institutions as well as industrial partners.

Together with our director, Giovanni Rovera, we will continue to foster the productive and innovative research that makes our institute unique.

SCIENTISTS AT THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
Philadelphia

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies